COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Theraclone Sciences develops human monoclonal antibodies for infectious diseases and cancer, using its I-STAR platform to screen immunologically relevant donors and advance clinical programs targeting influenza and HCMV.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors